Skip to main content
. 2021 Jun 8;14(6):550. doi: 10.3390/ph14060550

Figure 4.

Figure 4

Biodistribution profile and tumor targeting of the [68Ga]Ga-NOTA-mal-(hPD-L1) Nb at 80 min post-injection in hPD-L1POS tumor-bearing mice (n = 12) and in hPD-L1NEG tumor-bearing mice (n = 6), showing a significant difference (***, p < 0.001) between hPD-L1POS and hPD-L1NEG tumor uptake.